SDB-001 is discontinued (DEA controlled substance, Schedule I). SDB-001, formerly known as JWH-018, is a cannibimimetic. It is a CB (cannabinoid) receptor ligand that governs the cannabimimetic potency. Its role in binding CB receptors may be useful in therapeutic discovery for relief against MS, particularly when studying selective CB2 agonists. References: Banister SD, Wilkinson SM, Longworth M, Stuart J, Apetz N, English K, Brooker L, Goebel C, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. ACS Chem Neurosci. 2013 Jul 17;4(7):1081-92. doi: 10.1021/cn400035r. Epub 2013 Apr 17. PubMed PMID: 23551277; PubMed Central PMCID: PMC3715837.

纯度：≥98%

CAS：1345973-50-3